Lateral flow assays for detection of disease biomarkers
Journal of Pharmaceutical and Biomedical Analysis, 2023 Early diagnosis saves lives in many diseases. In this sense, monitoring of biomarkers is crucial for the diagnosis of diseases. Lateral flow assays (LFAs) have attracted great attention among paper-based point-of-care testing (POCT) due to their low cost, user-friendliness, and time-saving advantages.
Eda Gumus, Haluk Bingol, Erhan Zor
openaire +3 more sources
Novel African trypanocidal agents: membrane rigidifying peptides [PDF]
, 2012 The bloodstream developmental forms of pathogenic African trypanosomes are uniquely susceptible to killing by small hydrophobic peptides. Trypanocidal activity is conferred by peptide hydrophobicity and charge distribution and results from increased ...
Andreas Hartel +8 more
core +8 more sources
A lateral electrophoretic flow diagnostic assay [PDF]
Lab on a Chip, 2015 Antibodies against the hepatitis C virus are detected in human sera using the CellScope-enabled electrophoretic barcode assay.
Lin, Robert +5 more
openaire +4 more sources
Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya
African Journal of Laboratory Medicine, 2021 Background: Timely testing is a key determinant of management outcomes of coronavirus disease 2019 (COVID-19). Real-time reverse transcription polymerase chain reaction tests are currently the mainstay for COVID-19 testing.
James K. Kimotho +18 more
doaj +1 more source
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. [PDF]
, 2017 Purpose of reviewDiagnosis during early stages of invasive aspergillosis (IA) and targeted antifungal treatment has the potential to improve survival significantly.
Heldt, Sven, Hoenigl, Martin
core +1 more source
Towards Lateral Flow Quantitative Assays: Detection Approaches
Biosensors, 2019 Point-of-care (POC) or bedside analysis is a global trend in modern diagnostics. Progress in POC testing has largely been provided by advanced manufacturing technology for lateral flow (immunochromatographic) test strips.
Alexandr E. Urusov +2 more
doaj +1 more source
Aptamer-Based Lateral Flow Assays: Current Trends in Clinical Diagnostic Rapid Tests
Pharmaceuticals, 2022 The lateral flow assay (LFA) is an extensively used paper-based platform for the rapid and on-site detection of different analytes. The method is user-friendly with no need for sophisticated operation and only includes adding sample.
Marjan Majdinasab +2 more
doaj +1 more source
Evaluation of two lyophilized molecular assays to rapidly detect foot-and-mouth disease virus directly from clinical samples in field settings [PDF]
, 2017 Accurate, timely diagnosis is essential for the control, monitoring and eradication of foot‐and‐mouth disease (FMD). Clinical samples from suspect cases are normally tested at reference laboratories.
Armson, B. +14 more
core +1 more source
Direct detection and characterization of foot-and-mouth disease virus in East Africa using a field-ready real-time PCR platform [PDF]
, 2017 Effective control and monitoring of foot-and-mouth disease (FMD) relies upon rapid and accurate disease confirmation. Currently, clinical samples are usually tested in reference laboratories using standardized assays recommended by The World Organisation
Armson, B. +16 more
core +1 more source
Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of Schistosoma haematobium in low endemic settings [PDF]
, 2015 Elimination of schistosomiasis as a public health problem and interruption of transmission in selected areas are key goals of the World Health Organization for 2025.
Ali, Said M. +10 more
core +3 more sources